Article Details

Chinese biotech gets ok for Philippines mRNA COVID-19 omicron trial - Labiotech

Retrieved on: 2022-06-27 15:53:02

Tags for this article:

Click the tags to see associated articles and topics

Chinese biotech gets ok for Philippines mRNA COVID-19 omicron trial - Labiotech. View article details on hiswai:

Excerpt

It was developed by Wuhan Recogen Biotechnology Co., Ltd., a subsidiary of the company. R520A adopts a self-developed lyophilization technology ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up